Immuron Limited (IMRN)
NASDAQ·Healthcare·Biotechnology
$1.19
-4.44%
Mkt Cap $5.38M
No analyst coverage available
We don't have analyst ratings or price target data for Immuron Limited yet. Coverage gaps are common for sub-$1B market caps and recently-listed names.